“…It is believed that the IFN effects growth arrest through cellular functions of gene products, whose synthesis is induced or repressed by the IFN. The molecular changes include reduction in the activity of cyclin dependent kinase 2 (CDK2) in mouse embryonic fibroblasts (Bromberg et al, 1996), induction of expression of CDK2 inhibitor p21 in A431 cells (Chin et al, 1996), in glioblastoma cell lines T98G, SNB-19 and U-373 (Kominsky et al, 1998), in macrophages (Xaus et al, 1999) and in breast carcinoma MCF7 cells (Gooch et al, 2000), inhibition of cyclin A gene transcription in vascular smooth muscle cells (Sibinga et al, 1999), repression of cdk2 gene expression by the interference of interferon regulatory factor 1 (IRF1) with SP1dependent transcriptional activation of cdk2 promoter (Xie et al, 2003), hyperphosphorylation of retinoblastoma protein in mammary epithelial cells (Harvat and Jetten, 1996), and reduction in thymidine incorporation in WISH cells (Aharon et al, 2002). IFNg has also been found to induce or sensitise target cells to apoptosis through the induction of caspase 8 by IRF1 in Ewing tumor, neuroblastoma or medulloblastoma (Fulda and Debatin, 2002) or by downregulating the levels of p21 in human hepatocellular carcinoma cells (Detjen et al, 2003).…”